Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

New York Times - Sep 30, 2026

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Read full article

More News

The Next Discovery

The Next Discovery is equipped with recent Science & Tech news to impart knowledge to individuals awaiting the future.

NEWSLETTER